Key result
Early Parkinson's disease links to disrupted brain-heart coupling related to dysautonomia and dopaminergic state.
Why the study?
Although cardiovascular autonomic dysfunction is well established in Parkinson's disease, the brain and cardiovascular system are still largely investigated as separate domains, potentially overlooking the dynamic communication between them.
Does multimodal brain-heart coupling analysis detect disrupted central-cardiac coordination in patients with Parkinson's disease compared to healthy controls or isolated physiological measures?
Does multimodal brain-heart coupling analysis detect disrupted central-cardiac coordination in patients with Parkinson's disease compared to healthy controls or isolated physiological measures?
Evaluating dynamic brain-heart coupling uncovers disrupted central-cardiac coordination in Parkinson's disease that is missed when neural and cardiovascular signals are analyzed separately, offering a novel physiological framework for disease phenotyping.
Answers are grounded in this paper and cite their sources.
Supports brain-heart coupling as a hypothesis-generating phenotyping tool in Parkinson's disease; leaves open its clinical utility pending prospective validation.
Cardiovascular autonomic dysfunction is a well-established feature of Parkinson’s disease (PD), yet the brain and cardiovascular system are still largely investigated as separate physiological domains. This separation may overlook an important dimension of PD pathophysiology: the dynamic communication between them. Here, we examine emerging evidence that brain–heart coupling itself is altered in PD. A focused PubMed search identified studies directly relating neural activity to cardiac dynamics, complemented by relevant physiological and autonomic literature. Despite a small and heterogeneous evidence base, electrophysiological, neuroimaging, and dynamic network studies suggest disrupted central–cardiac coordination. Alterations are detectable in early and de novo PD, relate to dysautonomia, and appear sensitive to dopaminergic state. Emerging evidence for impaired cardiac interoception further suggests that dysfunction may extend from descending autonomic control to ascending heart-to-brain processing. Importantly, cross-system measures can reveal abnormalities that remain not captured by neural or cardiovascular signals alone. Their clinical potential is promising but remains to be established through larger, standardized, and longitudinal studies. At present, brain–heart coupling is best viewed as a physiological framework with emerging translational relevance rather than as a validated biomarker. By revealing interactions that remain hidden when neural and cardiovascular systems are examined separately, brain–heart coupling may uncover a distinct dimension of PD pathophysiology and provide a bridge from integrative physiology to disease phenotyping and future clinical stratification.
No takes yet. Share an insight, caveat, or question.
Pasquale Pagliaro (2026) conducted a review in Parkinson's disease. Simultaneous central neural and cardiac physiological assessment (brain-heart coupling) vs. Healthy controls or ON/OFF dopaminergic medication states was evaluated on Brain-heart coupling and central-cardiac coordination (e.g., EEG/fMRI dynamics coupled with HRV or heartbeat-evoked potentials). Brain-heart coupling analyses across 7 studies revealed disrupted central-cardiac coordination in early and de novo Parkinson's disease that relates to dysautonomia and dopaminergic state.
Synapse has enriched 10 related papers. Consider them for comparative context: